** Shares of blank check company Redwoods Acquisition Corps
RWOD.O up 26% at $13.10 in premarket trading
** Early-stage biotech ANEW MEDICAL Inc says will list on
Nasdaq via deal with Redwoods
** The deal values the combined company at $94 mln
** Transaction to provide $54 mln in cash proceeds, assuming
no redemptions by Redwoods stockholders
** ANEW intends to use the proceeds to advance its lead gene
therapy programs including for amyotrophic lateral sclerosis and
Alzheimer's disease
** Up to Friday's close, Redwoods stock was up 3.3% to
$10.40 this year
(Reporting by Pritam Biswas)
((pritam.biswas@thomsonreuters.com))